financetom
Business
financetom
/
Business
/
LIC Housing Finance expects improvement in net interest margin going ahead
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
LIC Housing Finance expects improvement in net interest margin going ahead
Jan 31, 2019 4:14 AM

LIC Housing Finance on Thursday said it expects improvement in net interest margin (NIM) going ahead after the company reported 25.5 percent jump in December quarter profit at Rs 596.31 crore, mainly due to higher interest income.

In an interview to CNBC-TV18, Vinay Sah, managing director and chief executive officer, said, "NIM for the quarter was 2.33 percent and for Q3FY18, it was 1.92 percent. Company's portfolio growth has been very good. For Q3, LIC Housing Finance grew at about 16.34 percent that is one of the best in the last 8-10 quarters."

Sah said, "The interest income growth from individual side is in the ratio of about 20 percent and on the developer side, the growth rate is 90 percent, but the share is only Rs 300 crore. So overall interest income, LIC Housing Finance is showing a growth rate of about 23 percent. Assets under management (AUM) has grown up by 16.34 percent. The retail portfolio has grown by about 14 percent. Both these percentages are the best in the last so many quarters."

On liquidity position, he said, "LIC Housing Finance did not experience any problem pertaining to liquidity in Q3. The only concern for the company was the rates at which money was available and because of that, our cost of borrowing went up by about 15 basis points (bps) in Q3."

One basis point is a hundredth of a percentage point.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
CORVEX TO GO PUBLIC IN ALL-STOCK MERGER WITH MOVANO, CREATING A PURE-PLAY PLATFORM FOR SECURE AI INFRASTRUCTURE AND HIGH-PERFORMANCE INFERENCE
CORVEX TO GO PUBLIC IN ALL-STOCK MERGER WITH MOVANO, CREATING A PURE-PLAY PLATFORM FOR SECURE AI INFRASTRUCTURE AND HIGH-PERFORMANCE INFERENCE
Nov 10, 2025
Strategic combination positions combined company to capture AI infrastructure demand at scale Movano shareholders gain exposure to rapidly emerging AI infrastructure pure play platform with differentiated product offering, a growing sales pipeline with attractive credit quality, leadership experienced in large-scale distributed computing and software development, and disciplined capital allocation Merger exchange ratio based upon a Movano per share value...
Capstone Reaffirms $100 Million 2026 Run-Rate Target with Acquisition Closing by December 15th
Capstone Reaffirms $100 Million 2026 Run-Rate Target with Acquisition Closing by December 15th
Nov 10, 2025
Acquisition of $15M stone distributor on track to close before December 15; the multi-location business will add revenue, EBITDA, and scale in a fast-growing category. NEW YORK CITY, NEW YORK / ACCESS Newswire ( ACCS ) / November 10, 2025 / Capstone Holding Corp. ( CAPS ) , a national building products distribution platform, today announced that it expects to...
Veradace Partners Issues Letter to Tiptree Shareholders Regarding the Proposed Sale of Fortegra to DB Insurance
Veradace Partners Issues Letter to Tiptree Shareholders Regarding the Proposed Sale of Fortegra to DB Insurance
Nov 10, 2025
Transaction Appears Designed to Enable Tiptree Management to Extract Value from Shareholders While Running a Blank Check Company Intends to Vote AGAINST the Unfair Transaction, Which Is Structured to Benefit Tiptree Management at the Expense of Tiptree Shareholders Urges the Tiptree Board of Directors to Restructure the Transaction and Deliver the $28.75 per Share Consideration Directly to Tiptree Shareholders,...
Lyell Immunopharma Acquires Exclusive Global Rights to a Next-Generation CAR T-Cell Product Candidate in Clinical Development for Metastatic Colorectal Cancer
Lyell Immunopharma Acquires Exclusive Global Rights to a Next-Generation CAR T-Cell Product Candidate in Clinical Development for Metastatic Colorectal Cancer
Nov 10, 2025
LYL273 has demonstrated a 67% overall response rate, an 83% disease control rate, and a manageable safety profile at the highest dose level studied to date in patients with refractory metastatic colorectal cancer enrolled in an ongoing U.S. Phase 1 clinical trialLYL273 is a GCC-targeted CAR T-cell product candidate armed with enhancements designed to improve CAR T-cell expansion and cancer...
Copyright 2023-2026 - www.financetom.com All Rights Reserved